{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:03:51Z","timestamp":1787015031734,"version":"build-2736575974"},"reference-count":20,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":6780,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1990,10]]},"abstract":"<jats:p>\n                    <jats:bold>Abstract:<\/jats:bold>\n                    Prognostic factors have been tested in patients with multiple myeloma treated according to a randomized trial of standard therapy versus 5\u2010drug combination therapy. The following population\u2010based study included 92 patients with a median age of 70 yr. The median survival was 31 months. The Cox regression model was used to search for predictors of survival. The cut\u2010off levels for blood analyses derived in earlier studies tended to select few patients in the high\u2010risk groups, for example only 8% of the patients had hemoglobin (Hb) \u2264 7.5 g\/dl. Lytic bone lesions in the pelvis or in the long bones, or spontaneous fractures and age &gt; 70 yr gave prognostic information in addition to anemia and impaired renal function. The MRC staging system was a better prognostic tool than the Durie &amp; Salmon stages. Palliative treatment regimens which take quality of life into account should be considered carefully in multiple myeloma patients &gt; 70 yr.\n                  <\/jats:p>","DOI":"10.1111\/j.1600-0609.1990.tb00457.x","type":"journal-article","created":{"date-parts":[[2010,7,17]],"date-time":"2010-07-17T22:30:30Z","timestamp":1279405830000},"page":"198-202","source":"Crossref","is-referenced-by-count":16,"title":["Prognostic factors in multiple myeloma in a population\u2010based trial"],"prefix":"10.1111","volume":"45","author":[{"given":"E.","family":"Hannisdal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Kildahl\u2010Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. A.","family":"Gr\u00f8ttum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lamvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1182\/blood.V55.6.1011.1011","article-title":"A new improved clinical staging system for multiple myeloma based on analysis of 123 treated patients","volume":"55","author":"Merlini G.","year":"1980","journal-title":"Blood"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1980.330"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000207722"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1980.328"},{"key":"e_1_2_1_7_2","first-page":"816","article-title":"Myelomatose","volume":"151","author":"Johnsen HE","year":"1989","journal-title":"Ugeskr L\u00e6ger"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197510)36:4<1192::AID-CNCR2820360403>3.0.CO;2-I"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1973.tb00073.x"},{"key":"e_1_2_1_10_2","first-page":"483","article-title":"Prognosis in myeloma: key role of uric acid in azotemia","volume":"21","author":"Cox EB.","year":"1980","journal-title":"Proc AACR-ASCO"},{"key":"e_1_2_1_11_2","first-page":"510","article-title":"Serum beta\u20102\u2010microglobulin in myelomatosis: potential value in stratification and monitoring","volume":"39","author":"Norfolk D.","year":"1979","journal-title":"Br J Cancer"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1988.tb00867.x"},{"key":"e_1_2_1_13_2","first-page":"145","article-title":"Proposed guidelines for protocol studies. II. Plasma cell myeloma","volume":"4","author":"Chronic Leukaemia\u2010Myeloma Task Force, National Cancer Institute.","year":"1973","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_14_2","first-page":"243","volume-title":"Recent advances in haematology","author":"Durie BGM","year":"1977"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(58)90126-7"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1977.1"},{"key":"e_1_2_1_17_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and lifetables","volume":"34","author":"Cox DR.","year":"1972","journal-title":"J R Stat Soc B"},{"key":"e_1_2_1_18_2","volume-title":"BMDP Statistical Software","author":"Dixon WJ","year":"1988"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19860715)58:2 <461::AID-CNCR2820581309>3.0.CO;2-L"},{"key":"e_1_2_1_20_2","first-page":"347","article-title":"The role of the sedimentation rate in the diagnosis of malignancy","volume":"67","author":"Beresford OD.","year":"1952","journal-title":"Can Med Assoc J"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2964(80)90136-X"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1990.tb00457.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1990.tb00457.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T21:24:27Z","timestamp":1740259467000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1990.tb00457.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,10]]}},"alternative-id":["10.1111\/j.1600-0609.1990.tb00457.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1990.tb00457.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,10]]}}}